MYELOABLATIVE DOSES OF BUSULFAN AND FLUDARABINE AS CONDITIONING FOR ALLOGENEIC STEM CELL TRANSPLANTATION IN NON-HODGKIN'S LYMPHOMA

被引：1
|
作者：
Figueroa, J. [1 ]
Perkins, J. [1 ]
Anassetti, C. [1 ]
Tomblyn, M. [1 ]
Field, T. [1 ]
Fernandez, H. [1 ]
Ochoa, J. [1 ]
Perez, L. [1 ]
Alsina, M. [1 ]
Locke, F. [1 ]
Nishihori, T. [1 ]
Pidala, J. [1 ]
Ayala, E. [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2012年 / 18卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2011.12.240
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
252
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [1] Myeloablative Intravenous Pharmacokinetically Targeted Busulfan Plus Fludarabine As Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients With Non-Hodgkin Lymphoma
    Ayala, Ernesto
    Figueroa, Javier
    Perkins, Janelle
    Kim, Jongphil
    Yue, Binglin
    Riches, Marcie
    Nishihori, Taiga
    Locke, Frederick
    Anasetti, Claudio
    Kharfan-Dabaja, Mohamed A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (06): : 335 - 340
  • [2] Comparison of fludarabine plus reduced versus myeloablative dose busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Kamijo, K.
    Shimomura, Y.
    Shinohara, A.
    Kim, S-W
    Ara, T.
    Mizuno, I.
    Eto, T.
    Nakazawa, H.
    Matsuoka, K-I
    Iida, S.
    Onizuka, M.
    Fukuda, T.
    Atsuta, Y.
    Kondo, E.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 38 - 39
  • [3] Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation
    Kimimori Kamijo
    Yoshimitsu Shimomura
    Akihito Shinohara
    Shohei Mizuno
    Minoru Kanaya
    Yoshiaki Usui
    Sung-Won Kim
    Takahide Ara
    Ishikazu Mizuno
    Takuro Kuriyama
    Hideyuki Nakazawa
    Ken-ichi Matsuoka
    Shigeru Kusumoto
    Nobuo Maseki
    Masaki Yamaguchi
    Takashi Ashida
    Makoto Onizuka
    Takahiro Fukuda
    Yoshiko Atsuta
    Eisei Kondo
    Annals of Hematology, 2023, 102 : 651 - 661
  • [4] Fludarabine plus reduced-intensity busulfan versus fludarabine plus myeloablative busulfan in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic cell transplantation
    Kamijo, Kimimori
    Shimomura, Yoshimitsu
    Shinohara, Akihito
    Mizuno, Shohei
    Kanaya, Minoru
    Usui, Yoshiaki
    Kim, Sung-Won
    Ara, Takahide
    Mizuno, Ishikazu
    Kuriyama, Takuro
    Nakazawa, Hideyuki
    Matsuoka, Ken-ichi
    Kusumoto, Shigeru
    Maseki, Nobuo
    Yamaguchi, Masaki
    Ashida, Takashi
    Onizuka, Makoto
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Kondo, Eisei
    ANNALS OF HEMATOLOGY, 2023, 102 (03) : 651 - 661
  • [5] Conditioning Regimen Comparison for Allogeneic Stem Cell Transplantation in non-hodgkin Lymphoma
    Peterson, Kristen
    Lin, Andrew
    Ruiz, Josel
    Zheng, Junting
    Devlin, Sean
    Shah, Gunjan
    Scordo, Michael
    Sauter, Craig
    Perales, Miguel
    Giralt, Sergio
    Buie, Larry
    Dahi, Parastoo
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 299 - 300
  • [6] Reduced-intensity conditioning with fludarabine/busulfan versus fludarabine/low-dose melphalan in patients with non-Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation
    Kamijo, Kimimori
    Shimomura, Yoshimitsu
    Kim, Sung-Won
    Ohigashi, Hiroyuki
    Ishikawa, Jun
    Eto, Tetsuya
    Hiramoto, Nobuhiro
    Mizuno, Ishikazu
    Iida, Shinsuke
    Ueda, Yasunori
    Matsuoka, Ken-ichi
    Yakushijin, Kimikazu
    Mori, Yasuo
    Onizuka, Makoto
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Kako, Shinichi
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (03) : 1097 - 1107
  • [7] Reduced-Intensity Conditioning with Fludarabine/Busulfan Versus Fludarabine/Low-Dose Melphalan in Patients with Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Kamijo, Kimimori
    Shimomura, Yoshimitsu
    Kim, Sung-Won
    Ara, Takahide
    Ishikawa, Jun
    Eto, Tetsuya
    Hiramoto, Nobuhiro
    Mizuno, Ishikazu
    Kusumoto, Shigeru
    Ueda, Yasunori
    Matsuoka, Ken-ichi
    Onizuka, Makoto
    Fukuda, Takahiro
    Atsuta, Yoshiko
    Kondo, Eisei
    BLOOD, 2022, 140 : 2393 - 2394
  • [8] Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Bhatt, Vijaya Raj
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2016, 11 (03) : 196 - 207
  • [9] Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma
    Vijaya Raj Bhatt
    Current Hematologic Malignancy Reports, 2016, 11 : 196 - 207
  • [10] Allogeneic haemopoietic stem cell transplantation for non-Hodgkin's lymphoma
    Toze, CL
    Barnett, MJ
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (03) : 481 - 504
12345